National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
raloxifene hydrochloride (ral-OX-ih-feen HY-droh-KLOR-ide)

 A drug used to reduce the risk of invasive breast cancer in postmenopausal women who are at a high risk of developing the disease or who have osteoporosis. It is also used to prevent and treat osteoporosis in postmenopausal women and is being studied in the prevention and treatment of other conditions. Raloxifene hydrochloride blocks the effects of the hormone estrogen in the breast and increases the amount of calcium in bone. It is a type of selective estrogen receptor modulator (SERM). Also called raloxifene and Evista.

Previous Definitions:radiosurgery, radiotherapy, radon, Raftilose Synergy 1, raloxifene
Next Definitions:raltitrexed, randomization, randomized clinical trial, ranpirnase, Rapamune